Medical Rehabilitation Services Market Size, Share, Growth, Trends | Report 2023-2032
The global medical rehabilitation services market was surpassed at USD 153.46 billion in 2022 and is expected to hit around USD 278.22 billion by 2032, growing at a CAGR of 6.13% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 153.46 billion |
| Revenue Forecast by 2032 | USD 278.22 billion |
| Growth rate from 2023 to 2032 | CAGR of 6.13% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Shirley Ryan AbilityLab; Prism Medical; Icahn School of Medicine at Mount Sinai; Paradigm Healthcare; The University of Chicago Medical Center; MindMaze Healthcare; Lifespan Physical Therapy Services; SuVitas; nMotion Physical Therapy; Therapy Solutions for Kids; Athletico Physical Therapy |
Medical rehabilitation services help in faster recovery, prevention, and management of injuries and chronic conditions, which is anticipated to bolster market growth. Patients suffering from conditions such as musculoskeletal, neurological, and cardiologic conditions usually benefit from rehabilitation services. For instance, Achilles tendonitis is a common injury among athletes that affects 250,000 of them every year. These patients could benefit from the rehabilitation services, thereby driving the market. Rehabilitation of patients with anterior cruciate ligament (ACL) injuries usually involves physical therapy to limit the activity of the knee, improve strength and stability, and regain full motion in the injured knee.
Moreover, increasing instances of drug abuse, alcoholism, and depression are projected to drive the demand for these services during the forecast period. As per data published by the WHO, as of 2021, 280 million people suffered from depression globally. Treatment of depression usually involves psychological treatments such as cognitive behavioral therapy, behavioral activation and interpersonal psychotherapy, and/or antidepressant medication. Moreover, the increasing geriatric population is projected to boost market growth. The geriatric population usually suffers from chronic conditions such as Alzheimer’s, arthritis, and cardiovascular diseases, which can be managed through this therapy. According to an article by Physiopedia, 11% of older patients are referred to rehabilitation facilities after hospitalization to improve functional capability and mobility.
Increasing government initiatives to improve the access to rehabilitation services are driving the market. For instance, in 2021, the U.S. introduced Increasing Access to Quality Cardiac Rehabilitation Care Act to improve patient access to pulmonary and cardiac rehabilitation services. Under this act, nurse practitioners, clinical nurse specialists, and physician assistants can suggest rehabilitation therapy for pulmonary and cardiac patients under Medicare. The bill is also expected to reduce delays, obstacles, and paperwork during the pre-rehabilitation process.
The COVID-19 pandemic had a negative impact on the market. Factors such as the cancelation of non-essential procedures and the lower number of patients undergoing rehabilitation services affected the growth. The market also witnessed a negative impact due to the shortages of healthcare professionals and restrictions on the movement imposed by the governments in order to curb the spread of the virus. Most of the hospitals and outpatient rehabilitation services worked at reduced capacity.
Medical Rehabilitation Services Market Segmentations:
| By Therapy | By Service | By Application | By End-use |
|
Occupational Therapy Speech and Language Therapy Physical Therapy Cognitive Therapy Others |
Outpatient Rehabilitation Services Inpatient Rehabilitation Services |
Orthopedic Neurological Cardiologic Pulmonary Sports Related Injuries Others |
Hospitals and Clinics Rehab Centers Homecare Settings Physiotherapy Centers |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Rehabilitation Market
5.1. COVID-19 Landscape: Medical Rehabilitation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Rehabilitation Market, By Therapy
8.1. Medical Rehabilitation Market, by Therapy, 2023-2032
8.1.1. Occupational Therapy
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Speech and Language Therapy
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Physical Therapy
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Cognitive Therapy
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Medical Rehabilitation Market, By Service
9.1. Medical Rehabilitation Market, by Service, 2023-2032
9.1.1. Outpatient Rehabilitation Services
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Inpatient Rehabilitation Services
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Medical Rehabilitation Market, By Application
10.1. Medical Rehabilitation Market, by Application, 2023-2032
10.1.1. Orthopedic
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Neurological
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Cardiologic
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Pulmonary
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Sports Related Injuries
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Medical Rehabilitation Market, By End-use
11.1. Medical Rehabilitation Market, by End-use, 2023-2032
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Rehab Centers
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Homecare Settings
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Physiotherapy Centers
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Medical Rehabilitation Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.1.2. Market Revenue and Forecast, by Service (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End-use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Service (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Service (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.2. Market Revenue and Forecast, by Service (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Service (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Service (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Service (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Service (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.2. Market Revenue and Forecast, by Service (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Service (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Service (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Service (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Service (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.2. Market Revenue and Forecast, by Service (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Service (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Service (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Service (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Service (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End-use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.5.2. Market Revenue and Forecast, by Service (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Service (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Therapy (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Service (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 13. Company Profiles
13.1. Shirley Ryan AbilityLab
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Prism Medical
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Icahn School of Medicine at Mount Sinai
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Paradigm Healthcare
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. The University of Chicago Medical Center
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. MindMaze Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Lifespan Physical Therapy Services
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. SuVitas
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. nMotion Physical Therapy
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Therapy Solutions for Kids
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers